Question follow-through · 115271
Idiopathic Pulmonary Fibrosis: Drugs
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 February 2026 to Question 110592, whether his Department has made an estimate of the earliest date nerandomilist could become available to patients after NICE publishes
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 23 Feb 2026
- Target answer date
- 2 Mar 2026
- Answer
- 2 Mar 2026 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- NHS: Redundancy Pay · 24 Feb 2026
- NHS: Redundancy Pay · 25 Mar 2026
- Amyloidosis: Diagnosis · 5 Jun 2026
- Amyloidosis: Diagnosis · 5 Jun 2026
- Medical Treatments: British Nationals Abroad · 5 Jun 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
23 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 February 2026 to Question 110592, whether his Department has made an estimate of the earliest date nerandomilist could become available to patients after NICE publishes
2 Mar 2026
Target answer date
Date supplied by the official written-questions record.
2 Mar 2026
Answer published
Subject to licensing, the National Institute for Health and Care Excellence (NICE) currently expects to publish final guidance on nerandomilast in September 2026. In formulating its recommendations, NICE's independent Appraisal Committee expects to hold i...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
NHS: Redundancy Pay
24 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of giving the NHS Staff Council a mandate to negotiate NHS partial retirement and statutory redundancy payments with trade unio
NHS: Redundancy Pay
25 Mar 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 March 2026 to Question 115765, on NHS: Redundancy Pay, whether he will consider giving the NHS Staff Council a mandate to negotiate NHS partial retirement and statutory
Amyloidosis: Diagnosis
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of access to SAP scanning for amyloidosis diagnosis for NHS patients in England; and what steps he is taking to ensure such diagnostic testin
Amyloidosis: Diagnosis
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of trends in the level of provision of SAP scanning for amyloidosis diagnosis for patients; and what assessment he has made of potential challenges to
Medical Treatments: British Nationals Abroad
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of people travelling abroad for medical treatment; what estimate he has made of the number of complications caused by overseas treatment requirin
Medical Treatments: British Nationals Abroad
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help improve patient awareness of the potential risks of undergoing medical procedures overseas.